Skip to main content
M

Moonlighttx

Moonlight Therapeutics is developing MOON101, an intradermal therapy designed to desensitize individuals with peanut allergies through a brief application process. This treatment aims to provide a safe and effective solution for managing food allergies, improving the quality of life for patients.

Atlanta, United StatesFounded 2017
Updated 4 months ago

Funding

$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Peanut allergies affect millions, causing anxiety and limiting food choices due to the risk of accidental exposure and severe reactions. Current management strategies often involve strict avoidance and carrying emergency epinephrine, which can be burdensome and does not address the underlying immunological sensitivity. Traditional allergy treatments may require frequent clinic visits and lengthy desensitization protocols.

Solution

Moonlight Therapeutics is developing MOON101, an intradermal patch designed to desensitize individuals with peanut allergies through brief, at-home applications. This therapy aims to reduce the severity of allergic reactions upon accidental peanut exposure, thereby improving quality of life. The MOON101 patch delivers a controlled dose of peanut allergen directly to the skin, potentially modulating the immune response and building tolerance over time. This approach offers a convenient and potentially safer alternative to traditional oral immunotherapy, with the goal of providing lasting protection against peanut-induced anaphylaxis.

Target Audience

The primary target audience includes individuals with diagnosed peanut allergies, as well as their families and caregivers seeking a more convenient and effective method for managing this condition.

Features

  • Intradermal delivery system for targeted allergen exposure
  • Brief application time, designed for convenient at-home use
  • Controlled dosage of peanut allergen to minimize adverse reactions
  • Potential to induce desensitization and reduce the severity of allergic reactions
  • Designed as a differentiated treatment for peanut allergy
This profile is AI-generated and may contain inaccuracies.